Literature DB >> 28329084

Obstructive Sleep Apnea is Associated With Early but Possibly Modifiable Alzheimer's Disease Biomarkers Changes.

Claudio Liguori1, Nicola Biagio Mercuri1,2,3, Francesca Izzi1, Andrea Romigi4, Alberto Cordella2, Giuseppe Sancesario3, Fabio Placidi1.   

Abstract

Study
Objectives: Obstructive sleep apnea (OSA) is a common sleep disorder. The, literature lacks studies examining sleep, cognition, and Alzheimer's Disease (AD) cerebrospinal fluid (CSF) biomarkers in OSA patients. Therefore, we first studied cognitive performances, polysomnographic sleep, and CSF β-amyloid42, tau proteins, and lactate levels in patients affected by subjective cognitive impairment (SCI) divided in three groups: OSA patients (showing an Apnea-Hypopnea Index [AHI] ≥15/hr), controls (showing an AHI < 15/hr), and patients with OSA treated by continuous positive airway pressure (CPAP).
Methods: We compared results among 25 OSA, 10 OSA-CPAP, and 15 controls who underwent a protocol counting neuropsychological testing in the morning, 48-hr polysomnography followed by CSF analysis.
Results: OSA patients showed lower CSF Aβ42 concentrations, higher CSF lactate levels, and higher t-tau/Aβ42 ratio compared to controls and OSA-CPAP patients. OSA patients also showed reduced sleep quality and continuity and lower performances at memory, intelligence, and executive tests than controls and OSA-CPAP patients. We found significant relationships among higher CSF tau proteins levels, sleep impairment, and increased CSF lactate levels in the OSA group. Moreover, lower CSF Aβ42 levels correlate with memory impairment and nocturnal oxygen saturation parameters in OSA patients. Conclusions: We hypothesize that OSA reducing sleep quality and producing intermittent hypoxia lowers CSF Aβ42 levels, increases CSF lactate levels, and alters cognitive performances in SCI patients, thus inducing early AD clinical and neuropathological biomarkers changes. Notably, controls as well as OSA-CPAP SCI patients did not show clinical and biochemical AD markers. Therefore, OSA may induce early but possibly CPAP-modifiable AD biomarkers changes. © Sleep Research Society 2017. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  continuous positive airway pressure; lactate; obstructive sleep apnea; subjective cognitive decline.; β-amyloid

Mesh:

Substances:

Year:  2017        PMID: 28329084     DOI: 10.1093/sleep/zsx011

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  55 in total

Review 1.  Disturbed sleep and diabetes: A potential nexus of dementia risk.

Authors:  Calliope Holingue; Alexandra Wennberg; Slava Berger; Vsevolod Y Polotsky; Adam P Spira
Journal:  Metabolism       Date:  2018-02-01       Impact factor: 8.694

2.  Continuous Positive Airway Pressure Treatment May Improve Optic Nerve Function in Obstructive Sleep Apnea: An Electrophysiological Study.

Authors:  Claudio Liguori; Fabio Placidi; Maria Giuseppina Palmieri; Francesca Izzi; Raffaella Ludovisi; Nicola Biagio Mercuri; Mariangela Pierantozzi
Journal:  J Clin Sleep Med       Date:  2018-06-15       Impact factor: 4.062

Review 3.  The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease.

Authors:  Andreia G Andrade; Omonigho M Bubu; Andrew W Varga; Ricardo S Osorio
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

4.  Proteomic biomarkers of sleep apnea.

Authors:  Aditya Ambati; Yo-El Ju; Ling Lin; Alexander N Olesen; Henriette Koch; Julien Jacques Hedou; Eileen B Leary; Vicente Peris Sempere; Emmanuel Mignot; Shahrad Taheri
Journal:  Sleep       Date:  2020-11-12       Impact factor: 5.849

Review 5.  Association of Sleep-Disordered Breathing With Cognitive Function and Risk of Cognitive Impairment: A Systematic Review and Meta-analysis.

Authors:  Yue Leng; Claire T McEvoy; Isabel E Allen; Kristine Yaffe
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

6.  Increased Cerebrospinal Fluid Amyloid-β During Sleep Deprivation in Healthy Middle-Aged Adults Is Not Due to Stress or Circadian Disruption.

Authors:  Margaret S Blattner; Sunil K Panigrahi; Cristina D Toedebusch; Terry J Hicks; Jennifer S McLeland; Ian R Banks; Claire Schaibley; Vitaliy Ovod; Kwasi G Mawuenyega; Randall J Bateman; Sharon L Wardlaw; Brendan P Lucey
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

7.  PAP use in mild cognitive impairment to delay progression to dementia.

Authors:  Michelangelo Maestri; Claudio Liguori; Enrica Bonanni; Biancamaria Guarnieri
Journal:  J Clin Sleep Med       Date:  2020-08-15       Impact factor: 4.062

8.  Use of positive airway pressure in mild cognitive impairment to delay progression to dementia.

Authors:  Virginia Skiba; Marina Novikova; Aarushi Suneja; Beth McLellan; Lonni Schultz
Journal:  J Clin Sleep Med       Date:  2020-06-15       Impact factor: 4.062

Review 9.  Obstructive Sleep Apnea and Its Treatment in Aging: Effects on Alzheimer's disease Biomarkers, Cognition, Brain Structure and Neurophysiology.

Authors:  Anna E Mullins; Korey Kam; Ankit Parekh; Omonigho M Bubu; Ricardo S Osorio; Andrew W Varga
Journal:  Neurobiol Dis       Date:  2020-08-27       Impact factor: 5.996

10.  Understanding Alzheimer's disease through the genetics of sleep.

Authors:  Ellen E Lee
Journal:  Int Psychogeriatr       Date:  2020-07       Impact factor: 3.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.